Sector Chart Supernus Pharmaceuticals, Inc.

SUPN

US8684591089

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Specialty & Advanced Pharmaceuticals

	Capi.	Finances	EV / Sales	P/E
SUPERNUS PHARMACEUTICALS, INC.	2.7B	-	-	-
MERCK KGAA	60.15B
KYOWA KIRIN CO., LTD.	8.58B
HALOZYME THERAPEUTICS, INC.	7.32B
SK BIOPHARMACEUTICALS CO., LTD.	7.06B
YUHAN CORPORATION	5.91B

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-12 EST			5-day change	1st Jan Change
47.16 ^USD	+1.40%		+3.24%	+30.42%

12-09	Supernus Pharmaceuticals Says Postpartum Depression Treatment Receives Authorization From Health Canada	MT
12-08	Supernus Pharmaceuticals, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 10:45 AM

Sector Chart Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Pharmaceuticals

Sector Specialty & Advanced Pharmaceuticals